150 related articles for article (PubMed ID: 18640298)
1. Trends in the operative management and outcomes of T4 lung cancer.
Farjah F; Wood DE; Varghese TK; Symons RG; Flum DR
Ann Thorac Surg; 2008 Aug; 86(2):368-74. PubMed ID: 18640298
[TBL] [Abstract][Full Text] [Related]
2. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
Martin LW; Correa AM; Hofstetter W; Hong WK; Komaki R; Putnam JB; Rice DC; Smythe WR; Swisher SG; Vaporciyan AA; Walsh GL; Roth JA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1601-10. PubMed ID: 16308005
[TBL] [Abstract][Full Text] [Related]
3. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
[TBL] [Abstract][Full Text] [Related]
4. Temporal trends in the management of potentially resectable lung cancer.
Farjah F; Wood DE; Yanez D; Symons RG; Krishnadasan B; Flum DR
Ann Thorac Surg; 2008 Jun; 85(6):1850-5; discussion 1856. PubMed ID: 18498783
[TBL] [Abstract][Full Text] [Related]
5. Surgical resection is justified in non-small cell lung cancer patients with node negative T4 satellite lesions.
Pennathur A; Lindeman B; Ferson P; Ninan M; Quershi I; Gooding WE; Schuchert M; Christie NA; Landreneau RJ; Luketich JD
Ann Thorac Surg; 2009 Mar; 87(3):893-9. PubMed ID: 19231415
[TBL] [Abstract][Full Text] [Related]
6. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD
J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986
[TBL] [Abstract][Full Text] [Related]
7. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
8. Surgical resection for multifocal (T4) non-small cell lung cancer: is the T4 designation valid?
Port JL; Korst RJ; Lee PC; Kansler AL; Kerem Y; Altorki NK
Ann Thorac Surg; 2007 Feb; 83(2):397-400. PubMed ID: 17257959
[TBL] [Abstract][Full Text] [Related]
9. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
[TBL] [Abstract][Full Text] [Related]
10. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
11. Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy.
De Waele M; Hendriks J; Lauwers P; Ortmanns P; Vanroelen W; Morel AM; Germonpré P; Van Schil P
Eur J Cardiothorac Surg; 2006 Feb; 29(2):240-3. PubMed ID: 16386916
[TBL] [Abstract][Full Text] [Related]
12. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
[TBL] [Abstract][Full Text] [Related]
13. Surgeon specialty and long-term survival after pulmonary resection for lung cancer.
Farjah F; Flum DR; Varghese TK; Symons RG; Wood DE
Ann Thorac Surg; 2009 Apr; 87(4):995-1004; discussion 1005-6. PubMed ID: 19324119
[TBL] [Abstract][Full Text] [Related]
14. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
16. Arterial invasion predicts early mortality in stage I non-small cell lung cancer.
Pechet TT; Carr SR; Collins JE; Cohn HE; Farber JL
Ann Thorac Surg; 2004 Nov; 78(5):1748-53. PubMed ID: 15511466
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting poor survival after resection of stage IA non-small cell lung cancer.
Chang MY; Mentzer SJ; Colson YL; Linden PA; Jaklitsch MT; Lipsitz SR; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2007 Oct; 134(4):850-6. PubMed ID: 17903494
[TBL] [Abstract][Full Text] [Related]
18. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
[TBL] [Abstract][Full Text] [Related]
19. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]